{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:57:46Z","timestamp":1790711866637,"version":"4.1.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,7,8]],"date-time":"2020-07-08T00:00:00Z","timestamp":1594166400000},"content-version":"am","delay-in-days":342,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["bmn.com","cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Trends in Microbiology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.tim.2019.05.005","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T18:18:55Z","timestamp":1559931535000},"page":"658-661","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Type IV Pili as a Therapeutic Target"],"prefix":"10.1016","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9174-9110","authenticated-orcid":false,"given":"Guillaume","family":"Dum\u00e9nil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tim.2019.05.005_bb0005","doi-asserted-by":"crossref","first-page":"267","DOI":"10.4155\/fmc-2016-0227","article-title":"Disarming pathogens: benefits and challenges of antimicrobials that target bacterial virulence instead of growth and viability","volume":"9","author":"Totsika","year":"2017","journal-title":"Future Med. Chem."},{"key":"10.1016\/j.tim.2019.05.005_bb0010","doi-asserted-by":"crossref","first-page":"887","DOI":"10.2217\/fmb.14.46","article-title":"Bacterial surface appendages as targets for novel antibacterial therapeutics","volume":"9","author":"Steadman","year":"2014","journal-title":"Future Microbiol."},{"key":"10.1016\/j.tim.2019.05.005_bb0015","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1002\/1439-7633(20011203)2:12<915::AID-CBIC915>3.0.CO;2-M","article-title":"Design and evaluation of pilicides: potential novel antibacterial agents directed against uropathogenic Escherichia coli","volume":"2","author":"Svensson","year":"2001","journal-title":"Chembiochem"},{"key":"10.1016\/j.tim.2019.05.005_bb0020","doi-asserted-by":"crossref","first-page":"8481","DOI":"10.1073\/pnas.1817757116","article-title":"Inhibitors of the Neisseria meningitidis PilF ATPase provoke type IV pilus disassembly","volume":"116","author":"Aubey","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2019.05.005_bb0025","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1038\/s41564-019-0395-8","article-title":"Targeting type IV pili as an antivirulence strategy against invasive meningococcal disease","volume":"4","author":"Denis","year":"2019","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.tim.2019.05.005_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/s41579-019-0195-4","article-title":"Type IV pili: dynamics, biophysics and functional consequences","author":"Craig","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.tim.2019.05.005_bb0035","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1084\/jem.168.4.1487","article-title":"Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans","volume":"168","author":"Herrington","year":"1988","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.tim.2019.05.005_bb0040","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1073\/pnas.84.9.2833","article-title":"Use of phoA gene fusions to identify a pilus colonization factor coordinately regulated with cholera toxin","volume":"84","author":"Taylor","year":"1987","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.tim.2019.05.005_bb0045","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1111\/j.1365-2958.2006.05061.x","article-title":"Direct repeat-mediated deletion of a type IV pilin gene results in major virulence attenuation of Francisella tularensis","volume":"59","author":"Forslund","year":"2006","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.tim.2019.05.005_bb0050","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003139","article-title":"Adhesion of Neisseria meningitidis to dermal vessels leads to local vascular damage and purpura in a humanized mouse model","volume":"9","author":"Melican","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tim.2019.05.005_bb0055","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1128\/jb.96.3.596-605.1968","article-title":"Neisseria gonorrhoeae. II. Colonial variation and pathogenicity during 35 months in vitro","volume":"96","author":"Kellogg","year":"1968","journal-title":"J. Bacteriol."},{"key":"10.1016\/j.tim.2019.05.005_bb0060","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.bbabio.2012.03.017","article-title":"Insights into the mechanism of electron transfer and sodium translocation of the Na(+)-pumping NADH:quinone oxidoreductase","volume":"1817","author":"Juarez","year":"2012","journal-title":"Biochim. Biophys. Acta"}],"container-title":["Trends in Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X19301337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0966842X19301337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T18:40:46Z","timestamp":1760812846000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0966842X19301337"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S0966842X19301337"],"URL":"https:\/\/doi.org\/10.1016\/j.tim.2019.05.005","relation":{},"ISSN":["0966-842X"],"issn-type":[{"value":"0966-842X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type IV Pili as a Therapeutic Target","name":"articletitle","label":"Article Title"},{"value":"Trends in Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tim.2019.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}